Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Mobile App in Development to Manage COPD

COPD Navigator screen. Click on image for a larger view. (LifeMap Solutions)

31 March 2015. A system combining an iPhone app and big data analytics is under development to help people with COPD manage their symptoms and health care providers monitor their condition. The COPD Navigator system is designed by LifeMap Solutions in San . . . → Read More: Mobile App in Development to Manage COPD

Nanoneedles Deliver Therapeutic DNA, Grow Blood Vessels

Electron microscope image of cell, in brown, on blue nanoneedles (Imperial College London)

31 March 2015. A device made of tiny nanoscale needles successfully delivered genetic material that encourages growth of blood vessels in lab animals, in tests of its therapeutic potential. Researchers from Imperial College London in the U.K. and Houston Methodist Research . . . → Read More: Nanoneedles Deliver Therapeutic DNA, Grow Blood Vessels

Novartis, Aduro Biotech Partner on Cancer Immunotherapy

T-cell (NIAID/NIH)

30 March 2015. The pharmaceutical company Novartis is licensing cancer immunotherapy technology from Aduro Biotech in Berkeley, California. The collaboration could earn Aduro as much as $750 million, including an equity stake, for access to its work on cyclic dinucleotides, still in preclinical study, but considered promising as a cancer treatment.

Cyclic . . . → Read More: Novartis, Aduro Biotech Partner on Cancer Immunotherapy

New Processes to Manufacture Food Sought in Challenge

(Jarmoluk, Pixabay)

27 March 2015. Sponsors of a new challenge on InnoCentive are seeking new manufacturing processes for making food and snacks. The competition has a total prize purse of $10,000 and a deadline of 23 April 2015 for submissions.

InnoCentive in Waltham, Massachusetts conducts open-innovation, crowdsourcing competitions for corporate and organization sponsors. The . . . → Read More: New Processes to Manufacture Food Sought in Challenge

Intermediate Trial Shows Ebola Vaccines Safe

Scanning electron micrograph of Ebola virus (National Institute of Allergy and Infectious Diseases)

27 March 2015. An intermediate-stage clinical trial in Liberia testing two new vaccines to prevent Ebola infections, shows the vaccines appear to be safe, allowing for larger-scale assessments. Initial results of the trial were reported yesterday by National Institute of Allergy . . . → Read More: Intermediate Trial Shows Ebola Vaccines Safe

Sharp Rise in Livestock Antimicrobial Use Expected

(Agricultural Research Service, USDA)

26 March 2015. An international research consortium estimates that global use of antibiotics in livestock is expected to jump by two-thirds by the year 2030, imperiling attempts to overcome antibiotic resistance and posing a threat to public health. The team led by Princeton University environmental researcher Ramanan Laxminarayan published its . . . → Read More: Sharp Rise in Livestock Antimicrobial Use Expected

Hand-Held DNA Sequencer IDs Bacteria, Viruses

MinIon device (Biomed Central)

26 March 2015. A palm-sized DNA sequencing device was able to identify a number of bacteria and viruses, and discriminate between closely related species in about 6 hours. Tests of the MinIon device, made by Oxford Nanopore Technologies in Oxford, U.K., were reported today in the journal GigaScience.

Oxford Nanopore . . . → Read More: Hand-Held DNA Sequencer IDs Bacteria, Viruses

FDA Approves Inhalational Anthrax Treatment

Anthrax spores (U.S. Food and Drug Administration)

25 March 2015. The U.S. Food and Drug Administration today approved a treatment for inhalational anthrax, a rare but dangerous respiratory condition that can result from a bioterrorist attack. The drug is marketed as Anthrasil by Emergent BioSolutions Inc. in Gaithersburg, Maryland.

Anthrax is caused by Bacillus . . . → Read More: FDA Approves Inhalational Anthrax Treatment

University Breeds Genome-Edited Pigs

(Beahohl/Pixabay)

25 March 2014. Veterinary researchers at University of Maryland successfully bred 18 pigs with their genomes edited by a technique that prominent geneticists recently called for strict guidelines. The university today announced birth of the baby pigs bred by animal sciences professor Bhanu Telugu and faculty research assistant Ki-Eun Park.

Telugu and Park . . . → Read More: University Breeds Genome-Edited Pigs

Stem Cell Biotech Gains $44M in First Venture Round

Human stem cell derived beta cells in mice (Doug Melton, Harvard University)

24 March 2015. A biotechnology start-up developing a stem-cell technology to replace missing beta cells that produce insulin for patients with type 1 diabetes, secured $44 million in its first venture funding round. Funding for Semma Therapeutics in Cambridge, Massachusetts was led . . . → Read More: Stem Cell Biotech Gains $44M in First Venture Round